EL, C., S, C., D, N., PB, C., M, L., G, G., & AK, I. (2019). Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAFV600E mutation bearing metastatic melanoma cells. Molecular carcinogenesis, 58(9), 1680. https://doi.org/10.1002/mc.23068
Chicago Style (17th ed.) CitationEL, Carpenter, Chagani S, Nelson D, Cassidy PB, Laws M, Ganguli-Indra G, and Indra AK. "Mitochondrial Complex I Inhibitor Deguelin Induces Metabolic Reprogramming and Sensitizes Vemurafenib-resistant BRAFV600E Mutation Bearing Metastatic Melanoma Cells." Molecular Carcinogenesis 58, no. 9 (2019): 1680. https://doi.org/10.1002/mc.23068.
MLA (9th ed.) CitationEL, Carpenter, et al. "Mitochondrial Complex I Inhibitor Deguelin Induces Metabolic Reprogramming and Sensitizes Vemurafenib-resistant BRAFV600E Mutation Bearing Metastatic Melanoma Cells." Molecular Carcinogenesis, vol. 58, no. 9, 2019, p. 1680, https://doi.org/10.1002/mc.23068.
